Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease

There are conflicting data regarding the use of hydroxychloroquine (HCQ) in COVID-19 hospitalized patients. The objective of this study was to assess the efficacy of HCQ in increasing SARS-CoV-2 viral clearance. Hospitalized adult patients with confirmed SARS-CoV-2 infection were retrospectively inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallat, Jihad, Hamed, Fadi, Balkis, Maher, Mohamed, Mohamed A., Mooty, Mohamad, Malik, Asim, Nusair, Ahmad, Bonilla, Maria-Fernanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769326/
https://www.ncbi.nlm.nih.gov/pubmed/33350752
http://dx.doi.org/10.1097/MD.0000000000023720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769326/
https://www.ncbi.nlm.nih.gov/pubmed/33350752
http://dx.doi.org/10.1097/MD.0000000000023720

Ejemplares similares